Braveheart Bio position history
The shares of Braveheart Bio that FARALLON CAPITAL MANAGEMENT, L.L.C. reported in each quarter’s 13F.
Shares held by quarter
New Add Reduce Exit
- 2026 Q3: 277,778 shares, $5.6M, 0.02% of portfolio, New
| Holdings date | Value | % of holdings | Shares | Filing date | All 13F holders |
|---|